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ABSTRACT 
BACKGROUND 
Autoreactive B cell (B-1a) may play a role in the pathogenesis of 
periodontal disease and this study was undertaken to elicit the autoimmune nature 
of B-1a cell in periodontal health and disease.  
MATERIALS AND METHODS 
Thirty gingival tissue samples were collected from two groups of 
patients (periodontal health-Group A and periodontal disease- Group B). The 
tissue sections were paraffanised and processed. B-1a cell expression in 
connective tissue was determined using CD5+ as a marker by 
immunohistochemical analysis. Intensity of staining was assessed and 
interexaminer error was calculated by kappa analysis. The mean labeling index 
was statistically analysed using independent ‘t’ test. 
RESULTS 
A good interexaminer agreement was observed between two examiners 
while assessing intensity. Comparison of mean labeling index between the two 
study groups was not statistically significant since p value was  >0.01                        
(p value = 0.276). 
 
CONCLUSION 
An increase in the number of autoreactive B-1a cells (CD5+) has been 
found in periodontitis as compared to healthy gingival specimens, which was 
found to be statistically insignificant.  
Keywords:  
 B-1a cells, Periodontitis, Immunohistochemistry 
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INTRODUCTION 
Periodontitis is a common multifactorial disease that leads to 
irreversible attachment loss, bone destruction and eventually tooth loss. 
Although the initiation of periodontal disease is thought to be of microbial 
origin
36 
further progression and tissue destruction is largely modulated by host 
related factors.
78 
Periodontal disease activity is generally accepted to be a 
result of an imbalance between periodontal pathogens and immune response of 
the host.
50
 
The definitive host response in periodontal disease is thought to be 
provided by adaptive immune responses as the disease process has largely 
been correlated to a few putative periodontopathogens.
89 
Page and Schroeder
 
1976
77
 reported that during the early stage of inflammation, the cellular 
infiltrate is mostly
 
T cells, whereas in the established lesions, B cells 
predominate. 
 In response to exogenous antigenic stimuli, the B-lymphocyte initiates 
humoral immune response. Initial exposure of immunocompetent                            
B-lymphocytes to foreign antigen at the site of entry or in peripheral lymphoid 
tissue results in sensitization of these B-cells and they respond by undergoing 
blastogenic transformation and replication to become a plasma cell that is 
capable of producing biologically active immunoglobulins.
25 
B-cells express 
the low affinity IgM constitutively which then undergo isotype switching to a 
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high affinity IgG. IgM and IgG2a activate the complement cascade to generate 
C3b and iC3b, which opsonise bacteria for phagocytosis. IgG1, IgG2b, and 
IgA bind to different Fc-R isoforms on macrophages, monocytes, and 
neutrophils via a separate internalization process to eliminate the 
pathogens.
65,71 
 B cells have been classified into conventional B cells (B-2 cells) and 
unconventional B cells (B-1 cells) which are further subdivided into B-1a cells 
& B-1b cells. 
 B-1 cells, first characterized by Hayakawa et al in 1985,
40 
express the 
phenotype `IgD low IgM high CD23- CD19+ CD11b+´ whilst conventional B 
cells are identified by the phenotype `IgD high IgM low CD23+ CD19+ 
CD11b- CD5-´. Further B-1a cells also referred to as autoreactive B cells; 
differ from B-1b cells by the expression of CD5 molecules in the former.
46
   
B-1a cells are predominantly found in pleural and peritoneal cavities, being 
few in the spleen and almost absent in lymph nodes and persist as self 
replenishing population.
12   
In adults they represent 10-25% of B cells in blood 
and about 15-30% in tonsil. Contrary to the bone marrow origin of 
conventional B cells, B-1 cells are long lived and auto renewing.
53
 
The concept of autoimmunity has in recent years, been expanded to 
include not only the typically autoimmune diseases, but also to chronic 
inflammatory lesions. Chronic inflammatory process that is characterized by 
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proteolytic breakdown of the extracellular matrix may result in formation of 
peptide/protein forms that may be perceived as foreign by the immune cells. 
These breakdown products may act as `foreign´, resulting in production of 
autoantibodies and/or evoking tolerogenic responses from the host. The 
presence of such autoimmune responses to collagen type 1 is common in 
chronic periodontitis, implying an  interplay between periodontal infection and 
autoimmunity.
45
 
 The concept of autoimmune reactions involved in periodontitis was 
introduced by Brandzaeg and Kraus,
16
 but there is no direct evidence linking 
them to tissue destruction. B-1a cells with autoreactive properties have been 
previously identified in periodontal disease.
10,23,94,5 
B-1a cells have been  
suggested to play a role in host immune response in periodontitis as plasma 
cells may develop from both conventional B cells (B2) and B-1a cells. 
 However the physiology of B-1a cells and their functions on the 
immune system as a whole is yet to be fully understood. This is most probably 
due to their paucity and localization and to the difficulties in their culture 
characteristics. 
 This study was undertaken to identify the presence of B-1a cells in 
gingival tissue with and without periodontal disease, so as to have an insight 
into their pathophysiological role. 
Aims & objectives 
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AIMS AND OBJECTIVES 
 
The aim and objective of the present study was 
 To identify the presence of B-1a cells in gingival tissues  
 To evaluate the number of B-1a cells in gingival tissues in periodontal 
disease and compare it with the healthy samples using 
immunohistochemistry. 
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REVIEW OF LITERATURE 
 Periodontitis is a chronic inflammatory disease of multifactorial origin, 
where there is a complex interplay between host immune complexes.
36
  
PATHOGENESIS OF PERIODONTITIS 
Changes in the biofilm mainly an increase in gram-negative micro-
organisms,
92
 with early vascular changes occuring in the periodontium, along 
with exudation and migration of phagocytic cells (neutrophils and 
monocytes/macrophages), into the junctional epithelium and gingival sulcus, 
resulting in initial gingival inflammation. These changes are accompanied by 
increase in the size of the connective tissue infiltrated by leukocytes and loss 
of perivascular collagen fibers. The resulting cellular and fluid exudates cause 
further breakdown of the adjacent connective tissue and epithelium, followed 
by proliferation, apical migration, and lateral extension of the junctional 
epithelium. All of these alterations contribute to periodontal pocket formation. 
 As the disease proceeds to more advanced stages, tissue destruction 
involves significant alveolar bone resorption and loss of the collagen      
needed for tissue attachment. Widespread manifestations of inflammatory and 
pathological responses associated with periods of quiescence and active 
exacerbation become evident.
70,79 
Much of the damage that occurs                    
in periodontitis is the result of host immune and inflammatory responses to the 
invading pathogens. The early contact and interactions between the acquired 
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immunity and different innate immune cells
7
 may have a drastic impact on the 
development of periodontal disease and/or its progression. It has been shown 
that both humoral and cell-mediated immune responses play important roles in 
the host defence against microbial infectious disease.
25
 
B-CELL-MEDIATED HUMORAL IMMUNITY AND 
PERIODONTITIS 
 Page and Schroeder 1976
77
 reported that during the early stage, the 
inflammatory infiltrate is mostly T-cells, whereas in the established lesions,   
B-cells become the most common inflammatory cells. 
 Seymour et al 1979
88
 have shown in his study that in the pathogenesis 
of chronic inflammatory periodontitis, there is a conversion from a stable               
T cell lesion to a progressive B cell lesion.         
 Janeway and Travers 1997
44
 stated that, after encountering invading 
pathogens, in particular extracellular micro-organisms, antigen (Ag)-specific 
naïve B-cells undergo affinity maturation via clonal selection, somatic 
hypermutation, and Ig receptor editing.  
 McGhee et al 1999,
65
 Nahm et al 1999
71 
suggested that certain 
cytokines such as interferon-γ (IFN-γ), interleukin- 4 (IL-4), IL-5, IL-10,              
IL-12, transforming growth factor-β (TGF-β) and bacterial lipopolysaccharide 
(LPS) are potent stimulators of Ab class switching i.e., IgG. Both IgM and 
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IgG2a (an IgG isotype) activate the complement cascade to generate C3b and 
iC3b, which opsonise bacteria for phagocytosis.  
 An early Ab-mediated control of periodontal infection through this 
process may limit the bacterial spread and/or associated tissue damage, 
thereby reducing the bacterial load for the subsequent acquired immune 
responses. Thus they are able to opsonise the invading pathogens, promote the 
FcR-mediated phagocytosis, neutralize the bacterial toxins, trigger 
complement-mediated lysis and Ab-dependent cytotoxicity and prevent 
bacterial entry at the mucosal surfaces, all of which enable the effective 
immune responses to provide the host protection from developing undesirable 
diseases.
71
 
DISTRIBUTION OF INFLAMMATORY CELLS IN PERIODONTITIS 
 Berglundh T et al 2005
9
 carried out a metaanalysis with regard to the 
cell composition in periodontitis lesions. It was reported that plasma cells 
represent about 50% of the cells present in lesions, while B cells comprise 
about 18%. The proportion of B cells was larger than that of all T cells and T 
helper cells were present in larger numbers than cytotoxic T cells. 
Polymorphonuclear leukocytes and macrophages were present at a proportion 
that represented about 5% of all cells.  
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 Mackler et al 1977
59
 collected gingival tissues from chronic 
periodontitis subjects and healthy/gingivitis subjects and concluded that 
periodontitis group contained higher concentration of lymphocytes and plasma 
cells (IgG, IgM). 
 Seymour & Greenspan 1979
88
 analysed 12 biopsies from chronic 
periodontitis patients and reported that majority of lymphocytes in the lesions 
had B cell phenotype and were positive for IgM and IgG. 
 Lindhe et al 1980
57
 assessed the composition of inflammatory 
infiltrates in gingival tissues obtained from 22 subjects with advanced 
periodontitis and reported that plasma cells occupied 31% of the lesion 
volume, while proportion of lymphocytes varied between 5% and 10%. The 
study concluded that volume of plasma cells was three times larger than the 
proportion of lymphocytes. 
Review of Literature 
 
 
9 
 
 
 
 Charon et al 1981
19
 analysed gingival biopsies from patients with 
advanced periodontitis and reported that plasma cells dominated the lesions. 
B CELLS AS ANTIGEN PRESENTING CELLS  
 The function of B cells in antigen presentation differs to some extent 
from that of other, so called professional antigen-presenting cells (APCs), e.g. 
Langerhans cells, macrophages and dendritic cells. Professional APCs take up 
antigens through pinocytosis or internalization of receptors for immune 
complexes, while B cells internalize antigens by an immunoglobulin-receptor 
(BCR) in the cell membrane. The antigen is degraded into peptides and 
subsequently attached to class II molecules of the major histocompatibility 
complex (MHC II). Finally, the processed antigen is transported to the B cell 
membrane for presentation to helper T cells (CD4+). B-1a cells may also serve 
as APCs in the development of an immune response to self-antigens.
56,81
 Thus, 
B cells express class-II antigens upon stimulation and use the capacity of their 
memory systems in antigen presentation in periodontitis lesions.  
 Orima et al 1999
75
 studied 14 patients with moderate to advanced 
adult periodontitis by taking gingival biopsy samples and an 
immunohistochemistry was done to detect the expression of CD 40, CD40L, 
CD80, and CD86 on lymphocytes. It was concluded that most T cells and B 
cells expressed CD28 and CD80 and CD86 respectively in gingival tissues. 
The distribution of CD40 cells was similar to that of CD19 cells and the 
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percentage of CD40 cells in CD19 cells was nearly 100, suggesting a role of     
B cell in antigen presentation. 
 Gemmel et al 2001
30
 studied 21 healthy individuals and 26 
periodontitis subjects by taking gingival biopsy samples. An immune 
peroxidase technique was used to examine CD28, CD152, CD80, and CD86 in 
T and B-lymphocytes and macrophages. This study concluded that there were 
a higher percentage of CD86 cells which suggests a predominance of Th2 
responses in both healthy and periodontitis tissues. The analysis of these cells 
in relation to the increasing numbers of B cells in proportion to T cells and 
also to macrophages, suggested that CD80 was expressed predominantly by 
macrophages while CD86 was expressed by both macrophages and B cells. 
 Mahanonda et al 2002
61
 who observed a significant upregulation of 
CD86 and the dendritic cell-marker CD83 on B cells in periodontitis lesions, 
suggested that B cells may serve as potent APCs in the host response of 
periodontal disease.  
 Gemmel et al 2002
29
 researched on the role of B cells as APCs in 
periodontitis in a study on gingival biopsies obtained from 26 subjects with 
periodontitis. The analysis revealed that the B cells were the predominant type 
of APCs in the biopsies containing the largest lesions. 
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B LYMPHOCYTE SUBSETS 
B cells develop from hematopoietic stem cells initially in the fetal 
liver before birth and subsequently in bone marrow.
39
 Among peripheral 
mature B cells there are 3 recognized subsets as identified in mouse models 
and to some extent in humans. First, B-1 cells, or unconventional B-lineage 
cells, are divided into B-1a and B-1b. The B-1a cells express the surface 
marker CD5, while B-1b cells do not. Second, B-2 cells, i.e. conventional B 
cells, are the traditional and representative B cells of the adaptive immune 
system. Third, marginal zone (MZ) B cells which are noncirculating mature B 
cells that segregate anatomically in the marginal zone of the spleen.
64,58
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 The B-2 cells participate in T-dependent germinal center (GC) 
reactions and yield isotype-switched, high-affinity memory cells and                 
long lived plasma cells. On the other hand, B-1 and MZ B cells are residing in 
specific anatomical compartments (e.g. peritoneal or pleural cavities and 
splenic MZ respectively) and are responsible for early antibody responses, 
which may be T cell independent as well as frequently polyreactive and with 
low-affinity.  
DEVELOPMENT AND FUNCTION OF B-1a CELLS 
 B-1 cells, first characterized by Hayakawa et al in 1985, express the 
phenotype `IgDlow IgMhigh CD23-CD19+CD11b+´ whilst conventional               
B cells are identified by the phenotype `IgDhigh IgMlow 
CD23+CD19+CD11b–CD5–´. Further, B-1a cells differ from B-1b cells by 
the expression of CD5 molecules in the former.  
 B-1a cells are distinguished from conventional B cells (B-2) by their 
developmental origin, their surface marker expression and their functions. 
Compared to B-2 cells, B-1a are long-lived and self-renewing, with reduced 
immunoglobulin receptor (BCR) diversity and affinity.
46
 B-1a cells also differ 
from B-2 by the expression levels of several surface markers, including IgM, 
IgD, CD5, CD43 and B220.
12
 
 In a recent study it was demonstrated that the expression of the   
marker CD5 makes B-1a cells survive following the immunoglobulin receptor 
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interaction.
28 
It was suggested that CD5 promotes downregulation of the early 
immunoglobulin receptor reactions and hence, prevents B-1a cells from 
immunoglobulin receptor-mediated cell death.  
 B-1a cells, following activation by T cells, undergo class switching and 
somatic mutation which result in changes from production of low-affinity 
autoantibodies to IgG auto-antibodies with high affinity.
97,24 
Recent studies 
have also shown that CpG microbial DNA released during infections may 
exacerbate autoimmunity by stimulating autoreactive B cells to switch from 
IgM to a more pathogenic IgG isotype independent from T cells.
41 
In addition, 
other characteristics, such as the production of high level of IL-10
74,93, 28, 67
 and 
enhanced antigen presentation capacities,
68,56,81 
have implicated B-1a cells in 
autoimmunity. 
IL-10 AND PERIODONTITIS – ROLE IN B1-A CELL 
PROLIFERATION 
 Interleukin-10 is a multifunctional cytokine with diverse effect on most 
hemopoietic cell types. It is produced by several cell sources such as 
monocytes/macrophages, dendritic cells (DC), B-lymphocytes (particularly the 
CD5+ B cells), various subsets of CD4+ and CD8+ T cells
69,67
 and also by 
human keratinocytes.
83
 The biological activities of IL-10 were confined to the 
suppression of pro-inflammatory cytokines produced by Th-1 cells
26 
(IL-2, 
IFNγ, TNFα), but today it is known that IL-10 has several effects in 
immunoregulation and inflammation. Thus, IL-10 inhibits MHC class II and 
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co-stimulatory molecule expression on monocytes and macrophages and 
inhibits macrophage microbicidal activity by downregulating the production of 
reactive oxygen and reactive nitrogen intermediates, which are involved in 
macrophage killing mechanisms.
69
 Other reports suggest that IL-10 may 
exhibit inhibitory and anti-inflammatory properties,
52,14
 
 The expression of CD5 on B1a cells has a dual regulatory role.    
Down-modulating the B1a cell responsiveness to BCR mediated signaling
13
 
and by this way controlling the production of a potentially autoreactive 
antibody repertoire, CD5 favours the secretion of interleukin-10 (IL10) by this 
cell subset.
28 
B-1a cells are major producers of IL10,
74 
a cytokine that 
contributes to the balance of type 1 and type 2 helper T cell (Th1/Th2) 
responses, that inhibit proinflammatory cytokine production by monocytes and 
macrophages and that controls the proliferation of antigen-specific CD4+ T 
cells by suppressing the antigen presenting capacity and decreasing co-
stimulatory molecule expression by professional antigen-presenting-cells.
22
 
Thus, through the secretion of IL10, B-1a cells contribute to the orchestration 
of cellular immune responses involved in inflammation and autoimmunity. 
 Levy & Brouet 1994
55
 showed that IL-10 enhances survival of normal 
human B cells (depending on their activation state), which correlates with 
increased expression of the anti-apoptotic protein bcl-2. Furthermore, IL-10 
promotes proliferation of autoreactive B cells and autoantibody production. 
Indeed, several autoimmune diseases have been associated with increased 
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levels of IL-10. The presence of IL-10 in periodontitis lesions has been 
reported previously.  
 Yamazaki and co-workers 1997
99
 applied a reverse transcription 
polymerase chain reaction technique to determine the level of mRNA for 
interferon gamma (IFNγ), interleukin 4 (IL-4), IL-10, IL-12 and IL-13 in 
gingival biopsies and peripheral blood mononuclear cells (PBMC) obtained 
from patients with chronic periodontitis. The mean expression of IFNγ was 
significantly higher in PBMC than in gingival tissues, while the expression of 
IL-10 mRNA was higher in gingival tissues than in PBMC.  
 Stein et al 1997
93
 showed an increased level of IL-10 together with 
large proportions of B-1a cells in type 1 diabetic patients. It was suggested that 
periodontal pathogens induce a hyperactive IL-10 response leading to 
proliferation of B-1a cells and   autoantibody production.  
 Aramaki and co-workers 1998
5
 analyzed gingival biopsies from 10 
periodontitis patients. It was observed that the proportion of autoreactive B 
lymphocytes (B-1a cells) and the amount of IL-6 and IL-10 were significantly 
higher in the inflamed gingival tissues than in peripheral blood from the 
healthy subjects. 
 Lappin and co-workers 2001
54
 analyzed the occurrence of different 
cytokines in periodontitis lesions. Tissue biopsies were retrieved from 10 
Review of Literature 
 
 
16 
 
 
 
patients with chronic periodontitis and 10 subjects with aggressive forms of 
periodontal disease. Polyclonal nonspecific antibodies and oligonucleotide 
probes were used to detect cells expressing IL-2, IL-4, IL-6, IL-10, IL-15, 
TNFα and IFNγ and they reported that the most widely expressed cytokine in 
gingival tissues was IL-10.  
 Beebe et al 2002
8
 stated that IL- 10 stimulates B cell proliferation, 
differentiation, antibody production and isotype switching.  
 Nakajima et al 2005
72
 reported that the expression of IL-10 was 
higher in periodontitis than in gingivitis lesions. Thus, IL-10 expression is 
associated with severe periodontitis and appears to be an important cytokine in 
the regulation of periodontitis lesions.  
ROLE OF SELF ANTIGENS 
Autoantibodies against a wide range of self-antigens, such as collagen 
type I (CI), host DNA, laminin, fibronectin, and desmosin, have been 
described.
4
  
 De-Gennaro and co-workers 2006
21
 showed increased autoantibodies 
to fibronectin and laminin, but not to CI, in patients with AgP. 
 Govze & Herzberg 1993
33
 analysed blood samples and GCF of 10 
periodontitis patients and showed increased reactions of IgG with 
desmoplakins and desmogleins, when compared to controls in sera. In GCF, 
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antidesmosomal IgG from diseased sites showed greater reactivity than 
healthy sites. 
 Schenkein et al 2003
87
 in his study reported that the prevalence of 
patients with chronic periodontitis and generalized periodontitis positive for 
anti cardiolipin was greater than that in healthy controls.  Analysis of data 
indicates that generalized periodontitis subjects have elevated levels of 
autoantibodies reactive with phospholipids. 
Auto-Antibody to Collagen 
 Autoantibody to collagen, detected in periodontal disease, may 
represent either a response to local tissue damage or be the manifestation of a 
disturbance of the host immune response induced by the periodontopathogens 
and its products.  
 Although B-cell hyper-responsiveness has been reported in periodontal 
disease,
3
 there is no evidence that patients who may possess an autoimmune 
predilection are also those who have high levels of antibody to collagen.  
 Grabar P 1975
34
 reported that the immune response to collagen may 
be a physiologic event, reflecting an attempt to remove damaged components 
from the inflamed site. 
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 Smith S 1980,
91 
Suzuki JB 1984
95
 stated that the reason for the raised 
level of collagen auto-antibody in periodontal disease is the action of the 
polyclonal B cell activators present in dental plaque. 
 Postlethwaite1984
82
 concluded in his study that the activation of 
cellular immune responses by collagen, acting as an autoantigen, would lead 
to participation of aggressive lymphocytes and to the release of lymphokines 
which may modify behaviour of adjacent cells. 
 Ftis et al 1986
27
 studied blood samples of 97 patients with periodontal 
disease by using ELISA and concluded that levels of antibody to type 1 
collagen detected in patients were higher (p value <0.001) than in control 
subjects. 
 Hirsch et al 1988
43
 in his study revealed that among the cells 
producing antibody to collagens I-VI sought in the diseased tissue, only cells 
producing antibody to collagen Type I, III, IV, V, and VI were increased in 
number, not those producing antibody directed against Type II collagen.  
 Peng TK et al 1988
80
 demonstrated the presence of elevated levels of 
antibody to collagen in the sera or cells producing antibody to collagen in 
tissue of patients with periodontal disease. 
 Guilbert B 1982,
35 
Avrameas S 1988
6
 stated that collagen is included 
in the list of self-antigens and is present at low levels in apparently healthy 
individuals.  
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 Rajapakse & Dolby et al 2004
85
 studied by taking gingival biopsy 
samples from 13 periodontitis patients and periodontally healthy patients 
subjects by ELISA method for detection of antibody to collagen and Pg in 
tissue elutes and serum. They concluded that level of antibodies to collagen 
type 1 and porphyromonas gingivalis in tissue were significantly higher than 
in serum. Antibody levels to Aa in tissue and serum were not significantly 
different from each other. 
 Koutouzis and co-workers 2009
51
 in a small pilot study have shown 
increased tissue autoreactivity and anti-CI antibody titers specifically in 
patients with localized AgP. 
Autoantibody to HSP60 
Heat shock protein 60 (HSP60) has also been suggested as another 
important candidate antigen. HSP60 belongs to a family of related proteins 
which have been conserved during evolution. Despite being highly 
homologous between prokaryotic and eukaryotic cells, HSP60 is strongly 
immunogenic, and immune responses to microbial HSP60 is speculated to 
initiate chronic inflammatory diseases in which autoimmune responses to 
human HSP60 may be central to pathogenesis.
47
 Major periodontopathic 
bacteria such as Porphyromonas gingivalis,
60
 Aggregatibacter 
actinomycetemcomitans,
73
 Fusobacterium nucleatum, Prevotella intermedia, 
Taneralla Forsythia
98
 and Campylobacter rectus
42
 are reported to produce 
HSP’s homologous to Escherichia coli GroEL.  
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 Tabeta K 2000
96
 demonstrated that the frequency of seropositivity and 
titers of antibodies to human HSP60 and P. Gingivalis GroEL were 
significantly higher in periodontitis patients than in periodontally healthy 
control subjects. Furthermore, affinity-purified serum antibodies to human 
HSP60 and P. Gingivalis GroEL cross-reacted with each other. These results 
suggest that an immune response based on the molecular mimicry between                   
P. Gingivalis GroEL and human HSP60 may play a role in periodontitis. 
 Yamazaki et al 2004
100
 studied blood samples of 21 patients with 
moderate to advanced chronic periodontitis to evaluate levels of antibody to 
human HSP60 before and after periodontal treatment by using ELISA and 
concluded that the mean level of anti human HSP60 antibody remained 
unchanged although individual levels of antibody either increased or 
decreased after periodontal treatment, suggesting that synthesis of these 
antibodies might be regulated independently during the course of periodontal 
infection. 
 Finally, the reason for the higher reactivity to HSP60 in periodontitis 
patients remains unknown. Further studies are required to elucidate the role of 
HSP60-specific T cells in chronic inflammatory conditions such as 
periodontitis. 
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ROLE OF B-1a CELL IN OTHER CHRONIC INFLAMMATORY 
LESIONS 
An increase in the numbers of CD5+ B-cells or B-1a cells has been 
reported in patients with several autoimmune diseases, including rheumatoid 
arthritis,
101
 Sjogren's syndrome,
103
 systemic lupus erythematosus
90
 etc. 
Diabetes Mellitus 
 In a study by Rebecca A. Smerdon et al  1994
86
 the percentage levels 
of total B-cells (CD20+) and the proportion expressing CD5 were increased in 
patients with recent-onset (P < 0.001 for both) but not long-standing type I 
diabetes compared with control subjects. Percentage levels of CD20+ B-cells 
were increased in prediabetic twins throughout the prediabetic period                         
(P < 0.05) and there was an increased proportion of CD5-expressing B-cells 
that failed to reach statistical significance (P = 0.08). Percentage levels of 
CD20+ B-cells and the proportion expressing CD5 were normal throughout 
the study in twins remaining nondiabetic. These results showed an increase in          
B-cell percentage levels at the time of diagnosis of type I diabetes, which is 
because of an expansion of the CD5+ subset. These changes are also evident 
in twins throughout the prediabetic period, which suggests that they are related 
to the processes that lead to diabetes mellitus.  
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 The role of CD5+ B-cells in the pathogenesis of autoimmune diseases, 
including type I diabetes, is unclear. The role of such an increase in B-cells in 
the pathogenesis of type I diabetes remains to be established. 
Rheumatoid Arthritis 
 Chung E 1974,
20 
Gosslau B 1979,
32 
Michaeli D  1974,
66 
Mammo W 
1982
62
 concluded in their study that both humoral and cell-mediated immunity 
to native and denatured Type I collagen is seen in the sera and synovial fluids 
of patients with rheumatoid arthritis, and it has been proposed that the 
autoimmunity may contribute to progression of the disease.  
            Hardy RR 1987
38
 stated that rheumatoid arthritis is characterized by 
an increase in the number of CD5+ B lymphocytes.  
 Kipps TJ 1987
48
   corroborates the findings of a study in monozygotic 
twins discordant for rheumatoid arthritis. In each case, the healthy twin had a 
level of CD5+ B cells similar to that of the twin with rheumatoid arthritis.  
 Burastero SE 1988
17
 did a study to determine the state of activation of 
fluorescence-activated cell sorted CD5+ and CD5- B cells in patients with 
active rheumatoid arthritis, investigated light-scattering properties and 
incorporation of [3H] thymidine. It was found that most CD5+ B cells, but 
very few CD5- B cells, from rheumatoid arthritis patients were low density, 
large-sized, spontaneously proliferating cells. Moreover, these CD5+ B 
lymphocytes, but not their CD5- counterparts, spontaneously secreted high 
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levels of IgM, IgG, and IgA RF. The fact that CD5+ B cells are activated, 
proliferating, and producing RF in rheumatoid patients may be consistent with 
a role for CD5+ B cells in the disease process. Thus, unlike CD5+ B cell 
frequency, the CD5+ B cell activation state may be an indicator of disease 
activity.  
 Burastero SE 1989
18
 with studies of rheumatoid arthritis patients 
demonstrated that CD5+ B cell levels did not correlate with RF levels in the 
serum. These findings suggest that CD5+ B cell frequency may not be directly 
related to disease activity, but rather to genetic background.  
 Youinou P 1990
101 
in their study on rheumatoid arthritis patients and 
their healthy relatives suggested that family members may also have elevated 
proportions of circulating CD5+ B cells.  
Chronic Lymphocytic Leukemia 
 Hall et al 2005
37
 studied patients with autoimmune haemolytic 
anaemia with chronic lymphocytic leukaemia. The study concluded that 
fractions of putative antigen presenting cell population from peripheral blood 
of patients by negative selection showed that CD5+ chronic lymphocytic 
leukaemia B cells are the most effective cell type in processing and presenting 
purified rhesus protein to autoreactive T helper cells. Thus it provided 
evidence for malignant cells driving an autoimmune response by acting as 
aberrant antigen presenting cells. 
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Systemic Lupus Erythematosus (SLE) 
 Smith HR et al 1990
90
 reported that in systemic lupus erythematosus 
the percentage of peripheral blood CD5+ B lymphocytes were increased to                
68 % when compared to normal.  
B-1a CELLS AND PERIODONTITIS 
 The presence of B-1a cells in periodontitis patients has been 
demonstrated in several reports.  
           Jonsson et al 1991
45
 reported that plasma cells in periodontitis may 
develop from both B-1a and B-2 cells and antibodies produced by plasma cells 
may also be autoantibodies. 
           Afar et al 1992
1
 collected blood samples from 18 patients with varying 
severity of periodontitis and from 16 healthy control subjects. Flow cytometry 
analysis revealed that B-1a cells occurred in significantly larger amounts in 
periodontitis patients than in controls.  
 Sugawara et al 1992
94
 studied blood samples, GCF and tissue biopsies 
from 20 periodontitis and 10 healthy controls and concluded that the 
percentage of B cells bearing CD5 surface marker was statistically significant 
in gingival than in peripheral blood obtained from both the patients and 
healthy subjects. Anticollagen IgG antibody level in patients GCF was higher 
than that in sera from healthy subjects and slightly higher than in autologous 
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sera. CD5+ B cells produced considerably more IgM and IgG antibody to 
collagen than CD5- B cells. 
 Aramaki et al 1998
5
 evaluated 34 adult periodontitis patients and 10 
periodontally healthy controls. Blood samples and tissue biopsy samples were 
considered for ELISA and two colour flow cytometry for the analysis of 
immunoglobulins, cytokines, CD20+ and CD5+. The study concluded that the 
proportion of B-1a cells and the amount of IL-6 and IL-10 were significantly 
higher in the inflamed gingival tissues than in peripheral blood from healthy 
subjects. 
 Berglundh et al 1999
11
 in a study on local and systemic features of 
host response in chronic periodontitis before and after non-surgical 
periodontal therapy found that the elevated numbers of B-1a cells did not 
decline after therapy despite the sufficient clinical signs of healing. Large 
amounts of B-1a cells were detected in the periodontitis lesions of chronic 
periodontitis patients in the study.  
 Berglundh et al 2002
10
 analyzed B-1a cells in peripheral blood of 3 
different groups of subjects; 22 subjects with severe generalized chronic 
periodontitis, 7 children with localized aggressive periodontitis and 26 healthy 
controls. The proportions of B-1a cells were 5-6 times greater in the 
periodontitis groups than in the controls and it was stated that up to 40-50 % 
of all circulating B (CD19+) cells were positive to the additional marker of 
CD5, i.e. the characteristic of B-1a cells. 
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           Donati et al 2009
23
 concluded in their study that B-1a cells constitute a 
significant part of the host response in periodontitis lesions and that plasma 
cells may develop from both B-2 and B-1a cells. 
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MATERIALS AND METHODS 
STUDY POPULATION 
 The study population comprised of randomly selected patients from 
those attending the Department of Periodontics, Ragas Dental College and 
Hospital, Chennai. The study protocol was approved by the Institutional 
Review Board of Ragas Dental College. Prior to conducting the study, 
informed consent was obtained after explaining the study protocol to the 
patients. A total of 30 patients were randomly selected for the study.  
The selected patients were divided into two groups: 
Group A: 15 periodontally healthy subjects (5 males & 10 females of age           
20-50 yrs (mean 35.6 years)) exhibiting no signs of periodontal disease as 
determined by the absence of  bleeding on probing (BOP) and clinical 
attachment loss (CAL) , with  probing depth (PD)≤ 3mm. 
Group B:  15 subjects with chronic periodontitis (7 males & 8 females of age 
20-65 yrs (mean 45.7 years)) exhibiting PD 5 mm, CAL ≥ 3 mm and 
presence of BOP in at least six sites.  
Inclusion criteria: 
1. Patients who were systemically healthy. 
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2. Patients who were non-smokers. 
3. No history of anti-microbial therapy for the past three months.   
Exclusion criteria:  
1. Patients who had received periodontal treatment within the previous 6 
months.  
2. Patients with other dental problems such as pulpal diseases. 
GINGIVAL TISSUE SAMPLE COLLECTION  
 Gingival tissue samples were obtained from periodontally healthy 
patients (Group A) during crown lengthening procedure, by placing an 
external bevel incision 1mm from gingival margin (1*3 mm tissue). 
 In patients with chronic periodontitis (Group B) gingival biopsy was 
obtained, one week after scaling and root planning (SRP). An internal bevel 
incision was placed 1mm from gingival margin (1*3 mm tissue) and tissue 
was excised during the modified Widman flap procedure. 
 The obtained gingival tissue specimens were fixed with 10% neutral 
buffered formalin. Prompt fixation was carried out to ensure the preservation 
of tissue architecture and cell morphology. The tissues were paraffin 
embedded within 48 hours, to avoid degradation of the antigens. 
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ARMAMENTARIUM FOR IMMUNOHISTOCHEMISTRY 
PROCEDURE 
Instruments/Equipments   
1. Aluminium foil 
2. Microscopic slides 
3. Detergent solution (Laxbro) 
4. Autoclave 
5. Beakers 
6. Coplin jars 
7. Cover slips 
8. Electronic timer 
9. Slide warming table 
10. Light microscope 
11. Measuring jar 
12. Micropipettes 
13. Rectangular steel trays with glass rods 
14. Refrigerator 
15. Sterile gauze 
16. Tooth forceps 
17. Diamond pencil 
18. Coulter´s chamber 
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19. Weighing machine (Sartorius) 
Reagents: 
1. Distilled water  
2. Acetone 
3. Xylene 
4. Absolute alcohol 
5. Alcohol 70% 
6. Alcohol 50% 
7. Hydrogen peroxide 3% 
8. EDTA buffer  (pH 8.0) 
9. Phosphate buffered saline (pH 7.0) 
10. Harris’s Hematoxylin 
11. DPX 
ANTIBODIES: 
Primary Antibody: 
 R& D systems, Human CD5 Affinity Purified Polyclonal Ab (100 UG); 
Catalog Number AF1636, Minneapolis, USA. 
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Immunohistochemistry Kit:  
 R & D systems Anti-Goat HRP-DAB Cell & Tissue Staining Kit; 
Catalog Number: CTS008; Minneapolis, USA. 
 Peroxidase Blocking Reagent - 6 mL of 3% Hydrogen 
Peroxide (H2O2). 
 Avidin Blocking Reagent - 6 mL of Avidin solution, 
containing 0.1% Sodium Azide (NaN3). 
 Biotin Blocking Reagent - 6 mL of Biotin solution, containing 
0.1% NaN3. 
 “Vial A” Secondary Biotinylated Antibodies  - 6 mL of 
either anti-mouse, anti-rabbit, anti-goat, anti-rat, or anti-sheep 
secondary antibodies, respectively, in 0.01 M PBS containing 
0.1% NaN3. 
 “Vial B” High Sensitivity Streptavidin-HRP Conjugate 
(HSS-HRP) - 6 mL of Streptavidin conjugated to HRP in            
0.01M PBS containing 1% carrier protein, with preservatives 
and stabilizer. 
 DAB Chromogen - 2 mL of 2.5% 3, 3- diamino benzidine 
(DAB) in stabilizing buffer. 
 DAB Chromogen Buffer - 2 vials (15 mL/vial) of 0.1% H2O2 
in Tris HCl Buffer. 
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SLIDE PREPARATION  
Precoating procedure 
 Before taking the sections onto the slide, all the slides were coated 
with APES    (3 amino- propyl tri- ethoxysilane). Pre coating procedure of the 
slides was as follows: 
 Slides were first washed in tap water for few minutes. 
 They were then soaked in detergent solution (Laxbro) for an hour. 
 After 1 hour each slide was brushed individually using the detergent 
solution and was transferred to distilled water. 
 Slides were washed in two changes of distilled water. 
 Later slides were washed in autoclaved distilled water. 
 The slides were then immersed in 1 N HCl overnight. 
 The following day the slides were washed in two changes of 
autoclaved distilled water. 
 All the slides were then transferred to slide trays, wrapped in 
aluminum foil and baked in hot air oven for 4 hours at 180
°
 c. 
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APES coating procedure: 
The slides were allowed to cool down and were then coated with APES 
using the following procedure. 
 Slides were dipped in a Coplin jar containing acetone for 2 minutes. 
 The slides were then dipped in a Coplin jar containing APES for 5 
minutes. 
 Following this, the slides were dipped in two changes of distilled water 
for  2 minutes each to remove excess APES and were left to dry. 
TISSUE SECTIONING 
 The paraffin embedded tissues were sectioned approximately 4 
microns thick using a manual rotary microtome.  
 The sections were placed in a water bath containing deionized distilled 
water preheated to 40-44º C to remove micro-wrinkles. 
 Two tissue sections were placed flat, wrinkle and fold free on the 
APES coated microscope slides. 
 Tissue sections were dried by placing on a slide warming table at           
100° C for 60 minutes. 
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IMMUNOHISTOCHEMISTRY (IHC) PROCEDURE 
Positive control 
 Tonsil specimens were used as positive control. 
Negative control 
 Gingival tissue to which primary antibody was not added, was used as 
negative control. 
 Immunohistochemistry procedure was carried out according to the 
R&D systems IHC protocol. 
Deparaffinisation of tissues sections                                        
 The slides with tissue sections were heated on a slide warming table at 
100˚C for 2 minutes. The slides were treated with two changes of xylene to 
remove paraffin wax. They were put in descending grades of alcohol and then 
rehydrated with Phosphate Buffered Saline (PBS). Circles were drawn around 
the tissues, so that the antibodies added later did not spread and were restricted 
to the circle. 
Antigen Retrieval 
 The slides were then transferred to coplin jars containing EDTA buffer 
and antigen retrieval was done in an autoclave at a temperature of 121°C and 
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pressure of 20psi for 15 minutes. Then the slides were allowed to cool till it 
reached room temperature.  
Staining procedure 
 The slides were treated with 3% hydrogen peroxide for 15 minutes to 
quench endogenous peroxidase activity of cells that would otherwise result in 
non – specific staining. The slides were put in one change of PBS. Slides were 
then treated with avidin blocking agent (R&D systems, CTS008, Minneapolis, 
USA)   for 15 minutess. Slides were rinsed in PBS following which the slides 
were treated with biotin blocking agent for 15 minutes. Avidin and biotin 
blocking agents were used to suppress endogenous avidin binding activity 
(EABA). Slides were again rinsed in PBS. 
 The primary antibody CD5 (R&D systems, AF1636, Minneapolis, 
USA) was added to the tissue on the slides. The stainless steel tray with glass 
rods containing the slides was incubated overnight at 2-8°C. The slides taken 
out were washed in three changes of cold PBS for 5 minutes each, to remove 
the excess antibody. Then the slides were wiped carefully without touching the 
tissue section to remove excess PBS. Then 1-3 drops of biotinylated secondary 
antibody (R&D systems, CTS008, Minneapolis, USA) was added onto the 
sections and the slides were incubated for 1 hour. Later the slides were washed 
in three changes of cold PBS for 15 minutes each. The slides were again 
wiped carefully without touching the tissue section to remove excess PBS. 
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Then 1-3 drops of HSS- HRP from the secondary antibody kit (R&D systems, 
CTS008, Minneapolis, USA) was added onto the sections and the slides were 
incubated for 30 minutes. The sections were then washed in three changes of 
cold PBS for 2 minutes each. Then the slides were again wiped carefully to 
remove excess PBS. Then a drop of freshly prepared DAB (diamino benzidine 
– a substrate Chromogen) (R&D systems, CTS008, Minneapolis, USA) was 
added onto the sections and incubated for 15 minutes. Slides were then 
washed in three changes of PBS for 10 minutes each and then rinsed in 
distilled water to remove excess DAB and counter stained with Harris’s 
Haematoxylin. They were then washed with alcohol and xylene. The tissue 
sections were mounted with DPX.  Throughout the procedure, care was taken 
not to dry the tissues.   
Observation: 
 All the slides were viewed under the light microscope at magnification 
10x and 40x. The slides were checked for positive staining in the tissue 
sections. The strong brown immunostaining exhibited by the gingival tissue 
was taken to be positive. Thus the intensity of staining and the number of cells 
in the connective tissue was recorded. 
 Positively stained cells seen in the inflammatory infiltrate of 
connective tissue in all the slides were examined. The intensity of staining was 
observed by two examiners and graded as Negative (-), mild (+), Moderate 
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(++) and Intense (+++). The inter-examiner variation was determined by 
kappa analysis.  
 The number of positive cells in the connective tissue was manually 
counted using Coulter`s chamber and the mean labelling index was calculated.  
                                         
                                         Number of positive cells        
                         LI   =   ---------------------------------------- × 100               
                                                      1000                        
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IHC PROCEDURE FLOW CHART: 
 
APES coated slides with sections preheated on slide 
 warming  table (100°C;2mins) 
 
Placed in xylene I (10 min) 
 
Placed in xylene II (10 min) 
 
Placed in 100% isopropanol (10 min) 
 
           Placed in 70% isopropanol (5 min) 
 
Placed in 50% isopropanol (5 min) 
 
                                        Washed in PBS (10 mins) 
 
Kept in EDTA buffer and autoclaved (20 psi ;15 mins) 
 
                                       Cooled to room temperature 
 
Placed in 3 % hydrogen peroxide (15 min) 
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Washed in PBS once (5 min) 
 
1-3 drops avidin blocking agent added (15 min) 
 
Rinsed in PBS 
 
1-3 drops biotin blocking agent added (15 min) 
 
Rinsed in PBS 
 
Primary antibody added & incubated for overnight at 2-8° C 
 
Washed thrice in PBS (5 mins) 
 
Incubated with 1-3 drops of biotinylated secondary antibody (1 hour) 
 
Washed thrice in PBS (15 min) 
 
Incubated with 1-3 drops of HSS- HRP (30 mins) 
 
Washed thrice in PBS (2 min) 
 
Materials and Methods 
 
40 
 
 
 
 
DAB was added and incubated (15 min) 
 
Washed with PBS thrice (10 min) 
 
Rinsed in distilled water (5 min) 
 
Stained with haematoxylin (30 seconds) 
 
Washed in distilled water 
 
                                 Placed in 70% isopropanol (5 min) 
 
Placed in 100% isopropanol (5 min) 
 
Placed in xylene (5 min) 
 
Slides were mounted using DPX 
 
Slides were observed under the microscope 
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STATISTICAL ANALYSIS 
 Data entry and descriptive analysis was performed using SPSS version 
10.0.5. Mean LI and standard deviation was calculated to assess
 
B-1a (CD5+) 
expression.
  
 The intensity of staining was determined by two examiners and the 
inter-examiner variation was determined by kappa analysis. 
 Independent `t´ test was used to compare the two groups, (Healthy and 
Chronic Periodontitis) with regard to the CD5 expression. 
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RAGAS DENTAL COLLEGE AND HOSPITALS, CHENNAI. 
DEPARTMENT OF PERIODONTICS 
PROFORMA 
NAME:                              AGE:                      SEX:                   DATE: 
ADDRESS:                                                      OCCUPATION:                                 
 
OP.NO: 
CHIEF COMPLAINT: 
 
PAST DENTAL HISTORY: 
 
MEDICAL HISTORY: 
 
PERSONAL HABITS: 
 
INTRAORAL EXAMINATION: 
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A.HARD TISSUE EXAMINATION: 
 
 
B.SOFT TISSUE EXAMINTAION: 
- GINGIVAL FINDINGS 
 
 
 
 
- DENUDED ROOTS (MILLERS CLASSIFICATION) 
 
 
Materials and Methods 
 
44 
 
 
 
 
 
 
Measurement of Probing Depth and Clinical Attachment Loss 
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PROVISIONAL DIAGNOSIS: 
 
TREATMENT PLAN: 
 
 
 
 
BIOPSY DETAILS: 
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CONSENT FORM 
 I,_______________________________________s|o,w|o,d|o________
____________ aged about _____ years Hindu/Christian/Muslim/ 
____________ residing at ______________________________________do 
hereby solemnly and state as follows.  
 I am the deponent herein; as such I am aware of the facts stated here 
under.  
 I state that I came to Ragas Dental College Hospital, Chennai for my 
treatment for   ………………………………………………………  
I was examined by Dr. ___________________________ and I was requested 
to do the following tests. 
1.  
2.  
3.  
 I was also informed and explained about the pros and cons of the 
treatment / test in the __________________ (language) known to me. 
 I was also informed and explained that the results of the individual test 
will not be revealed to the public. I give my consent after knowing full 
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consequences of the dissertation/ thesis /study and I undertake to cooperate 
with the doctor for the study. 
 I also assure that I shall come for each and every sitting without fail. 
 I also authorize the doctor to proceed with further treatment or any 
other/suitable/alternative method for the study. 
 I have given voluntary consent to undergo treatment without any 
individual pressure. 
 I am also aware that I am free to withdraw the consent at any time 
during the study in writing. 
 
Signature of the Patient/Attendant 
 The patient was explained the procedure by me and he has understood 
the same and with full consent signed in (English/ Tamil/ Hindi/ Telugu/ 
____________) before me. 
                                                                                       Signature of the Doctor 
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RESULTS 
 A total of 30 gingival tissue samples (15 health and 15 diseased) were 
evaluated for expression of CD5. (The results are summarized in Table 1 & 
Table 2) 
Assessment of intensity 
 All the tissues were assessed for intensity of staining in gingival 
connective tissue. Intense staining was observed in 3 specimens in group A 
and 4 specimens in group B. Moderate staining was observed in 3 specimens 
in group A and 6 specimens in group B. Mild staining was seen in 3 specimens 
in group A and 4 specimen in group B. Brown staining was not seen in 1 
specimen in group A. Therefore only 14 specimens in group A expressed CD5 
in connective tissue while all 15 specimens in group B were positive for CD5 
in gingival connective tissue. A good inter examiner agreement was observed 
between the two examiners (H-0.796, D-0.797).  
Cell counting 
Immunostaining of gingival connective tissue showed localization of 
CD5 to inflammatory infiltrate in connective tissue. The number of positive 
cells in lamina propria was evaluated using mean labeling index. The results 
of the mean labeling index were as follows: in group A, the mean labeling 
index was 39.72±9.49; in group B, 44.19±11.44. There was no statistically 
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significant difference in the mean labeling index between the two study 
groups, since p value is >0.01 (p =0.276). 
Figure 1, 2,3 & 4 describes B-1a cells (CD5+) expression in health and disease  
when viewed under light microscope at 10x and 40x. 
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Table 1.  
Tabulation of Intensity and Labelling Index in Gingival Tissue Samples 
S.              
NO. 
AGE/S
EX 
SITE PPD CAL 
Proce-
dure 
Inten-
sity 1 
Intensity 
2 
LI 
SLIDE 
NO. 
1. 39/M 27-B 222 - C L* ++ +++ 39.77 4585 
2. 20/F 17-B 2 3 3 - CL + + 22.58 4519 
3. 41/M 37-L 3 3 2 - CL + ++ 32.32 4380 
4. 49/F 36-B 3 3 3 - CL +++ +++ 46.45 4521 
5. 24/F 37-L 2 3 3 - CL + + 34.44 4464 
6. 25/F 25-P 2 2 2 - CL + + 44.23 4694 
7. 37/F 46-B 3 2 3 - CL + + 32.45 4561 
8. 24/F 36-L 3 3 3 - CL ++ ++ 34.53 4234 
9. 21/F 13-P 2 2 2 - CL +++ +++ 58.36 4555 
10. 25/F 25-B 3 2 3 - CL ++ ++ 43.16 4592 
11. 44/M 36-L 3 3 3 - CL + + 39.69 4509 
12. 32/F 21-P 2 3 3 - CL +++ +++ 53.14 4627 
13. 22/M 46-L 3 2 3 - CL + + 35.22 4437 
14. 22/F 13-P 2 2 2 - CL + + -ve (>10 cells) 4345 
15. 24/F 36-L 3 3 3 - CL -ve -ve * -ve 4560 
16. 60/F 11- P 6 6 6 7 7 7 MWF* ++ ++ 27.88 4359 
17. 43/M 16-P 9 9 7 10 11 8 MWF + + 61.96 4499 
18. 39/M 46- B 10 6 8 12 7 8 MWF +++ +++ 57.40 4327 
19. 48/M 47-B 10 8 8 10 9 9 MWF +++ +++ 57.34 4488 
20. 36/F 17-P 7 6 8 8 7 9 MWF + + 41.95 4443 
21. 40/F 46-L 8 6 8 9 8 9 MWF ++ ++ 40.70 4554 
22. 48/F 34-B 9 7 9 10 9 10 MWF ++ ++ 50.64 4540 
23. 38/F 45 -L 6 5 6 777 MWF + ++ 24.44 4612 
24. 37/F 46 -B 5 6 8 7 7 9 MWF ++ ++ 34.93 4379 
25. 37/F 46 -L 6 4 6 7 5 7 MWF ++ ++ 31.91 4344 
26. 37/F 16 -B 8 8 8 10 9 9 MWF + + 55.98 4247 
27. 43/M 27-B 8 6 8 9 8 9 MWF + + 43.32 4674 
28. 45/M 25-B 5 7 7 7 8 8 MWF ++ + 39.68 4720 
29. 58/M 16-B 7 10 8 9 10 9 MWF +++ +++ 51.76 4711 
30. 55/M 23-B 6 8 8 7 10 9 MWF +++ +++ 42.92 4719 
*B- Buccal, P- Palatal, L- Lingual, CL- crown lengthening, MWF- modified 
Widman flap, -ve - Negative 
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Table 2. 
Comparison of Intensity Scoring and Mean Labelling Index Between 
Health and Disease 
 Group A(health) 
Group B 
(periodontal 
disease) 
p value 
intensity 
Intense - 3 
Moderate - 3 
mild – 8 
Negative-1 
Intense – 5 
Moderate – 6 
mild – 4 
 
- 
mean LI± SD 39.72+-9.49 44.19+-11.44 .276 
 [p value: <0.001- statistically significant; p value >0.001- not statistically 
significant] 
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Fig.1: EXPRESSION OF B-1a CELLS (CD5+) IN HEALTH (10x) 
 
 
FIG.2: EXPRESSION OF B-1a CELLS (CD5+) IN HEALTH (40x) 
 
                                             -  indicates positive staining 
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Fig.3: EXPRESSION OF B-1a CELLS (CD5+) IN DISEASE (10x) 
 
 
 
Fig.4: EXPRESSION OF B-1a CELLS (CD5+) IN DISEASE (40x)
 
                                             -  indicates positive staining 
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DISCUSSION 
 Periodontal disease is a chronic inflammatory disease of multifactorial 
origin in which the normal balance between microbial plaque and host 
response is disrupted.
78
 The pathogenesis of periodontal disease process 
involves both innate and adaptive responses which are specifically tailored 
against the microbial challenge. The host response is largely directed against 
exogenous antigens that are derived from periodontopathogenic bacteria such 
as Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola.
92
  
 Seymour et al 1979
88
 have shown in their study that in the 
pathogenesis of chronic inflammatory periodontitis, there is a conversion from 
a stable T cell lesion to a progressive B cell lesion. Evidence for the 
importance of B cells in periodontal disease has come from the following 
studies. Lindhe et al 1980
57
 assessed the composition of inflammatory 
infiltrates and reported that the volume of plasma cells was three times larger 
than the proportion of lymphocytes. Gmur et al
31
 reported that IgG antibody 
levels to Porphyromonas gingivalis were highly correlated with the extent of 
periodontal destruction. Zambon et al
102
 stated that there was a significantly 
increased antibody response to A.actinomycetemcomitans in localized early 
onset periodontitis. 
 B cells also serve as APCs and express class II antigens upon 
stimulation and use the capacity of their memory systems in antigen 
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presentation. Mahanonda et al 2002
61
 showed a significant increase in CD86 
and dendritic cell marker CD83 on B cells in periodontitis lesions and thus 
concluding that B cells may serve as potent APCs in immune response of 
periodontal disease. 
 B-1 cells, or unconventional B-lineage cells, are divided into B-1a and 
B-1b. B1a cells have the property of autoreactivity and self renewal. B-1 cells 
form a dominant population of B lineage cells in the peritoneal cavity.
48
 The 
B-1a cells express the surface marker CD5, while B-1b cells do not.
64
 The 
CD5 B cells (B-1a) and their phenotypic CD5 “twins” (B-1b cells) differ from 
conventional peripheral B cells (B-2) by anatomical location, developmental 
origin, surface marker expression, antibody repertoire and growth 
properties.
40,63
 B-1a cells also differ from B-2 by the expression levels of 
several surface markers, including IgM, IgD, CD5, CD43 and B220.
12
 
Brandzaeg and Kraus 1965
16
 showed the presence of autoantibody producing 
plasma cells in periodontitis lesions. 
 Autoimmunity is a condition characterized by a specific humoral or 
cell-mediated immune response against the constituents of the body's own 
tissues (autoantigens). An increase in the numbers of CD5+ B-cells or B-1a 
cells has been reported in patients with several autoimmune diseases, 
including rheumatoid arthritis
101 
systemic lupus erythematosus
90 
and type 1 
diabetes mellitus.
86 
Autoantigenicity may also be found in other chronic 
inflammatory disorders. Autoantibodies against a wide range of self-antigens, 
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such as collagen type I (CI), host DNA, laminin, fibronectin, and desmosin, 
have been described.
4
 Ftis et al
27
 have demonstrated the presence of elevated 
levels of antibody to collagen in the sera or cells producing antibody to 
collagen in tissue of patients with periodontal disease. 
 The present study was carried out to evaluate the expression of B-1a 
cell (CD5+) in gingival tissue in health and periodontal disease. Previous 
studies in this department have been carried out with other aspects of 
autoimmunity such as HSP60 and T regulatory cells. As sequel of previous 
studies, this study was conducted to have a better understanding of the 
autoreactivity of B-1a cells in periodontal disease.   
 Health samples were collected from subjects with PD <3mm, absence 
of CAL and absence of BOP (indicative of lack of inflammation) during 
crown lengthening by gingivectomy. Disease samples were collected from 
subjects with PD ≥5mm and CAL ≥ 3mm, during internal bevel incision given 
during flap surgery. All biopsy specimens obtained were fixed in formalin and 
paraffinised within 48 hours to prevent any loss of detail of the antigen 
structure. From each tissue portion, thin sections were prepared using 
microtome and exposed to immunohistochemical staining.  
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CD5 was chosen as a marker for the immunohistochemical analysis because. 
 CD5 is the distinguishable feature between B1 and B2 cells as well as 
B-1a and B-1b cells  
 CD5 has its role in B1a clonal expansion 
 The inter-examiner variation for intensity was evaluated to remove 
bias and was analysed by kappa analysis, which showed a good interexaminer 
agreement (health - 0.796; disease - 0.797). The cells were manually counted 
under 40x magnification and the mean labelling index for the total number of 
cells was calculated and a value of 0.276 was obtained.  
           The comparative results showed that there was an increase in the 
number of B-1a cells in periodontitis group compared to health, but not 
statistically significant. 
 Previous studies have validated the presence of B-1a cells in 
periodontal disease. The results of our study are in partial agreement with the 
studies of Donati et al
23
 who showed that two thirds of B lymphocytes were 
positive for CD5 marker (B-1a) in tissue samples with periodontitis,             
Aramaki et al
5
 and Berglundh et al
10
 showed that 48.9% & 30-60% of B cells 
in periodontitis lesions were B-1a cells respectively. In contrast to the above 
studies, no comparative evaluation of the B-1a/B cell ratio was undertaken in 
our study. Therefore, the population of these cells in relation to total B cell 
infiltrate could not be evaluated. The significant difference between health and 
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disease previously reported could be related to the use of different, presumably 
more sensitive protein detection methods. 
 Our results are also in partial agreement with Afar et al
1
 who reported 
significant increase in CD5+ B cells in peripheral blood of patients with 
chronic periodontitis. The study was however carried out in circulatory levels, 
unlike ours on gingival tissue samples. 
 The results of our study suggest that there may be a putative role for   
B-1a in the pathogenic process in chronic periodontitis. A previous study in 
this department on a tolerogenic immune cell (Treg cells), yielded similar 
results. Taken together, these results suggest that autoimmune destructive 
process may play a small but an important role in pathogenesis of periodontal 
disease. 
 The increase in number of B-1a cells (CD5+) in periodontal disease 
may be explained as follows: 
 The conversion of autoreactive B cells to B1 cell derived mononuclear 
phagocyte (B1-DMP). B-1 cells migrate from the peritoneal cavity to a 
site of non-specific inflammation where they become morphologically 
similar to monocytes derived macrophages and have a high phagocytic 
ability.
2,15
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 B-1a cells undergo class switching and somatic mutation which result 
in changes from production of low-affinity autoantibodies to IgG auto-
antibodies with high affinity.
24,97
 
 Periodontal pathogens may induce a hyperactive IL-10 response 
leading to proliferation of CD5 positive B cells and to auto-antibody 
production.
28,67,74,93 
Indirect evidence for this is derived from 
autoantibodies directed against collagen
51
 and HSP60.
100
                                                     
 The clinical implications of B-1a cells are yet to be fully elucidated. 
However, it is clear that the role of B cells is not unidimensional; it may play 
both destructive and protective roles. Therefore, treatment strategies in 
periodontal disease need to be directed not only against exogenous antigens, 
but also to host modulatory components.  
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SUMMARY AND CONCLUSION 
 The present study was undertaken to evaluate the expression of          
B-1a cell in gingival health and disease tissue samples. The study population 
comprised of 30 patients and were divided into two groups,                      
Group A (healthy gingiva) and Group B (chronic periodontitis). 
 Gingival biopsies were taken and all tissue samples were paraffinised 
and processed. B-1a (CD5+) expression was determined using Human       
CD5 Affinity Purified Polyclonal Ab employing immunohistochemical 
procedures. Brown staining observed in the connective tissue infiltrate was 
considered positive. Samples were analyzed for intensity of staining and cell 
counting was done to calculate the number of positively stained cells.  
 Assessing the intensity using kappa analysis, good inter examiner 
agreement was observed between the two examiners (H-.796, D-.797). The 
mean labeling index between the two study groups using independent ‘t’ test 
yielded a p value of 0.276.  
From the results of this study we may conclude that: 
 There was an increase in the number of autoreactive B-1a                     
cells (CD5+) in periodontitis as compared to health, which was                       
found to be statistically insignificant. Further studies with greater                    
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sample size and statistically significant data are needed to confirm                  
the role played by B-1a cells in the etiopathogenesis of periodontal               
disease. 
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